Buscar en
Endocrinología y Nutrición
Toda la web
Inicio Endocrinología y Nutrición Present recommendations in type 2 diabetes treatment
Información de la revista
Vol. 56. Núm. S4.
14.° Simposio Científico Diabetes Mellitus Hoy
Páginas 46-49 (Diciembre 2009)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 56. Núm. S4.
14.° Simposio Científico Diabetes Mellitus Hoy
Páginas 46-49 (Diciembre 2009)
Diabetes mellitus hoy
Acceso a texto completo
Present recommendations in type 2 diabetes treatment
Visitas
1588
Harold E. Lebovitz
Autor para correspondencia
hlebovitz1@hotmail.com

Correspondence: Department of Medicine, División of Endocrinology. State University of New York Health Science in Brooklyn. 450 Clarkson Avenue. Brooklyn. New York 11203. USA.
State University of New York Health Science in Brooklyn. Brooklyn. New York. USA
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
References
[1.]
D.M. Nathan, J.B. Buse, M.B. Davidson, E. Ferranninni, R.R. Holman, R. Sherwin, et al.
Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy.
Diabetes Care, 32 (2009), pp. 193-203
[2.]
UK Prospective Diabetes Study Group.
Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34).
Lancet, 352 (1998), pp. 854-865
[3.]
S.H. Choi, K.Y. Hur, D.J. Kim, C.W. Ahn, E.S. Kang, B.S. Cha, et al.
Staged diabetes management according to individual patient insulin resistance and β-cell function ameliorates glycaemic control in type 2 diabetes mellitus.
Clin Endocrinol(Oxf), 69 (2008), pp. 549-555
[4.]
Canadian Diabetes Association 2008.
Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
Canadian Journal of Diabetes, 32 (2008), pp. S1-201
[5.]
P.S. Jellinger, J.A. Davidson, L. Blonde, D. Einhorn, G. Grunberger, Y. Handelsman.
Road maps to achieve glycemic control in type 2 diabetes mellitus: ACE/AACE Diabetes Road Map Task Force.
Endocr Pract, 13 (2007), pp. 260-268
[6.]
Duckworth W. Veterans Affairs Diabetes Trial: Results. Presented at the 68th Annual Scientific Sessions of the American Diabetes Association 2008 Annual Meeting.
[7.]
W. Duckworth, C. Abraira, T. Moritz, D. Reda, N. Emanuele, P.D. Reaven, et al.
Glucose control and vascular complications in veterans with type 2 diabetes.
N Engl J Med, 360 (2009), pp. 129-139
[8.]
H.C. Gerstein, M.E. Miller, R.P. Byington, D.C. Goff Jr., J.T. Bigger, J.B. Buse, ACCORD study group, et al.
Effects of intensive glucose lowering in type 2 diabetes.
N Engl J Med, 358 (2008), pp. 2545-2559
[9.]
DCCT/EDIC Research Group.
Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy. The Epidemiology of Diabetes Interventions and Complications (EDIC) Study.
JAMA, 290 (2003), pp. 2159-2167
[10.]
R.R. Holman, S.K. Paul, A. Bethel, D.R. Matthews, H.A.W. Neil.
Ten year follow-up of intensive glucose control in type 2 diabetes.
N Engl J Med, 359 (2008), pp. 1565-1576
[11.]
Lebovitz HE. Present recommendations in type 2 diabetes mellitus treatment. Chapter 15. Lilly Book on Type 2 Diabetes.
[12.]
P. Gaede, H. Lund-Andersen, H.-H. Parving, O. Pedersen.
Effect of a multifactorial intervention on mortality in type 2 diabetes.
N Engl J Med, 358 (2008), pp. 580-591
Copyright © 2009. Sociedad Española de Endocrinología y Nutrición
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos